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ARTICLE
Artiﬁcial coiled coil biomineralisation protein for
the synthesis of magnetic nanoparticles
Andrea E. Rawlings 1,2,4, Lori A. Somner1,4, Michaela Fitzpatrick-Milton1, Thomas P. Roebuck3,
Christopher Gwyn2, Panah Liravi3, Victoria Seville1, Thomas J. Neal1, Oleksandr O. Mykhaylyk 1,
Stephen A. Baldwin3 & Sarah S. Staniland 1,2
Green synthesis of precise inorganic nanomaterials is a major challenge. Magnetotactic
bacteria biomineralise magnetite nanoparticles (MNPs) within membrane vesicles (magne-
tosomes), which are embedded with dedicated proteins that control nanocrystal formation.
Some such proteins are used in vitro to control MNP formation in green synthesis; however,
these membrane proteins self-aggregate, making their production and use in vitro challenging
and difﬁcult to scale. Here, we provide an alternative solution by displaying active loops from
biomineralisation proteins Mms13 and MmsF on stem-loop coiled-coil scaffold proteins
(Mms13cc/MmsFcc). These artiﬁcial biomineralisation proteins form soluble, stable alpha-
helical hairpin monomers, and MmsFcc successfully controls the formation of MNP when
added to magnetite synthesis, regulating synthesis comparably to native MmsF. This study
demonstrates how displaying active loops from membrane proteins on coiled-coil scaffolds
removes membrane protein solubility issues, while retains activity, enabling a generic
approach to readily-expressible, versatile, artiﬁcial membrane proteins for more accessible
study and exploitation.
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he pursuit of designer magnetic nanoparticles has spanned
several decades and has lately warranted increasing
research activity as the number of technological applica-
tions for nanomaterials grows1,2. Applications range from high
density recording media for information storage3, ferroﬂuids for
high frequency electronics4, as well as several biomedical5–7 such
as MRI contrast enhancing agents8,9, site-speciﬁc chemo10, and
hyperthermic11 cancer treatments, as well as targeted drug
delivery systems9,12. All nanomagnetic applications have speciﬁc
requirements for the nanoparticles they utilise with respect to
quality, size, shape, coatings, stability, and composition2,11,13. The
ultimate goal within this research area is to synthesise magnetic
nanoparticles with precise nanoscale control over these proper-
ties. While this may be possible for a range of sizes and some
morphologies, the chemical methods generally utilise toxic pre-
cursors and solvents, as well as harsh reaction conditions, which
raises issues with biocompatibility of the resulting materials and
the environmental sustainability of the process. Some researchers
are developing alternative strategies, for example by ﬁne tuning
reaction conditions in room temperature conditions14. However,
ambient, biologically compatible conditions typically produce ill-
deﬁned particles over a large size range2. Furthermore, there are
many desirable shapes and sizes which are extremely difﬁcult to
access synthetically15.
Achieving reproducible control on such small length scales
using environmentally sustainable chemistry has presented a
formidable challenge for researchers, leading us to look towards
biology for a solution. Living organisms form intricate inorganic
materials with nanoscale precision through biomineralisation.
Nature biomineralises these materials from the bottom up; pro-
ducing unparalleled control over the materials size, shape, and
composition1. One such material is the magnetic nanoparticles of
magnetite, produced in magnetotactic bacteria (MTB)16. These
bacteria contain unique organelles, termed magnetosomes
(Fig. 1a)17–19. The magnetosome, an intracellular vesicle struc-
ture, is made of lipid membrane and harbours an array of dif-
ferent proteins20–22. These unique proteins control and mediate
key aspects of the particle formation; from facilitating iron inﬂux
across the membrane to nucleation of iron ions, as well as con-
trolling the ﬁnal morphology of the mature nanoparticle18. This
latter group of proteins, able to inﬂuence the ﬁnal morphology,
size, and characteristics of the mature crystal, represent a pro-
mising source of control agent additives to regulate the formation
of synthetic magnetite nanoparticles (MNPs). This has been
demonstrated with several such magnetosome membrane speciﬁc
(Mms) proteins, mediating the crystallisation of highly homo-
geneous MNPs when added to a simple, green, magnetite che-
mical precipitation reaction23–25. Mms6 was found tightly bound
to the magnetite crystal within the magnetosome and so identiﬁed
as a good candidate to control a reaction in vitro23. Mms6 was the
ﬁrst protein to be used in synthetic magnetite formation
reactions23,26–28, and was found to increase the particle’s crys-
tallinity, as well as constraining the size to 21–22 nm in most
cases28. Mms13 (MamC) was also found tightly bound to the
mineral in vivo23, and this too has been puriﬁed and added to
magnetite precipitation, resulting in an increase in particle size25.
Mms6 from Magnetospirillum magneticum AMB-1, and the
Mms13 homologue, MamC, in Magnetococcus marinus, have
been shown to bind iron ions, indicating a possible role in
magnetite nucleation23,29–32. Genetic studies show that MmsF
could be another protein of interest. The mmsF gene is found in
the same gene cluster as mms6, and knock out mutations ofmmsF
and the whole gene cluster in M. magneticum AMB-1 resulted in
smaller misshapen magnetosomes33. However, reintroducing
mmsF into the strain with the whole gene cluster missing, rescued
the formation of the wild-type magnetosomes, showing MmsF to
be independently crucial in controlling morphology33. We found
that MmsF could also affect the crystallisation of magnetite
MNPs when added to a simple room temperature co-
precipitation synthesis, tightly deﬁning the morphology24.
However, a major bottleneck to exploitation is the trans-
membrane spanning nature of these proteins which have one,
two, and three such regions in Mms6, Mms13, and MmsF,
respectively34. Membrane proteins are extremely hydrophobic,
and therefore challenging to both purify and utilise in aqueous
solution without the addition of stabilising detergents or other
amphiphilic additives35. Some of the magnetosome proteins,
although possessing transmembrane helical regions, are in fact
able to be refolded from inclusion bodies when over-expressed in
Escherichia coli to form water-soluble assemblies (Mms6 and
MamC)23,25, or can even be expressed as water-soluble multi-
meric structures directly (MmsF)24. However, the yield of these
proteins is often low, and the high degree of self-assembly makes
structural and functional studies more challenging.
The Mms proteins, which interact with the magnetite crystal
directly, do so via the parts of the polypeptide chain which reside
within the magnetosome lumen. In the case of MmsF and Mms13,
this sequence most likely lies within the intra-protein loop con-
necting transmembrane helices 1 and 234,36. These short peptide
sequences would normally be presented to the magnetite nano-
crystal as a constrained loop, anchored in place by two trans-
membrane spanning helices (Fig. 1b). Both of these proteins have
been shown to be active in synthetic magnetite precipitation reac-
tions in their full length form24,25, where they improve the uni-
formity of the nanoparticle product. However, the production and
puriﬁcation of such proteins is low yielding and not trivial. There is
a compelling need to develop more easily expressible, soluble, high
yielding, robust proteins, with the same or similar functionality, to
act as viable additives for the green synthesis of MNP. There has
been progress towards this using many different approaches such as
combinatorial and screening methodologies37,38.
Scaffold proteins have generated signiﬁcant interest over recent
years as researchers seek to engineer proteins with unique
properties. Most scaffold proteins feature a highly stable core
structure, able to tolerate signiﬁcant modiﬁcation of surface
exposed loops. Well characterised examples include DARPins39,
Afﬁbodies40, and Adhirons41. Recently, Adhirons and Maltose
binding protein (MBP) have been used successfully to display
both artiﬁcial and naturally occurring magnetite interacting
peptides42–44. Coiled coils represent a structural protein motif
that is widespread in nature45,46. They comprise two or more
alpha-helices which wrap around one another in a supercoiled
assembly47. The helices can adopt either a parallel or antiparallel
arrangement depending on the N to C terminal direction of each
helix with respect to the other. The driving force of the assembly
process in aqueous solution is the burying of the hydrophobic
residues arranged along a single interior face of each helix. This is
achieved by programming the coiled coil assembly into the pri-
mary structure of the peptide via a heptad repeat sequence; pla-
cing hydrophobic, charged, and polar residues at strategic sites
along its length48. Designed coiled coils have been used for a
number of innovative applications including as MRI contrast
reagents and molecular motors49,50. Many examples of engi-
neered coiled coils are available, where the designers have selected
parallel or antiparallel coils, and dimeric or multimeric inter-
molecular and intramolecular assemblies, depending on the
desired structure and application48,51–54. An antiparallel
arrangement of helices lends itself to the formation of a hairpin,
helix-turn-helix structure, if both helices are part of the same
molecule and their termini are bridged by a peptide (Fig. 1c)55.
Here, we report a simple, artiﬁcial biomineralisation protein,
based on the active sequences from multi-transmembrane Mms
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protein loops. We have developed an artiﬁcial scaffold protein to
display these peptide loops in an attempt to mimic the topology
of the full length proteins, and exploit just those parts which are
capable of interacting with magnetite directly. Our scaffold is a de
novo protein architecture based upon an antiparallel coiled coil
hairpin. In this study, we demonstrate the success of using this
constrained bridging peptide to display the magnetite interacting
loops of Mms13 and MmsF, and show that the MmsF displaying
coiled coil (MmsFcc) controls particle formation in vitro com-
parably to MmsF, while the results with Mms13cc may allude to
Mms13’s function in vivo. This stem-loop coiled coil (SLCC)
scaffold could in principle be applied to other transmembrane
proteins with solvent exposed loop regions, simply by modifying
the linking peptide sequence. Therefore a full range of different
functionalities could in theory be conferred onto this versatile
scaffold, with particular signiﬁcance for intractable membrane
proteins.
Results
Production and characterisation of the coiled coil proteins. To
design our SLCC scaffold we utilised a de novo peptide sequence
which has previously been demonstrated to form intermolecular
antiparallel coiled coil assemblies45. This sequence can dimerise to
form a stable coiled coil structure and features a gradient of
negative to positively charged residues (N to C) along the length of
each coil. The presence of these charges helps to maintain, through
favourable charge–charge interactions, the antiparallel, rather than
parallel topology56. We used the TMpred server to estimate the
location of membrane spanning helices in MmsF, and Mms13
from M. magneticum AMB-1, as well as the acriﬂavin efﬂux pro-
tein AcrB from E. coli as a negative control (Supplementary Fig. 1)
57. The experimentally determined topology of Mms1336, and the
predicted topology of MmsF34, allowed us to identify the loop
sequences which are expected to reside within the lumen of the
magnetosome and connect two transmembrane helices. The
sequences of these loops were incorporated into the construct
design (Fig. 1c). Models of the coiled coil construct suggest the
coils are separated at the bridging loop position by 9.8 Å. This
compares favourably with the 10.6 Å separation between helices 4
and 5 in AcrB, and 9.5 Å and 10.6 Å separation in the models of
MmsF and Mms13, respectively, meaning the loops are likely to be
displayed in a similar fashion to that expected in the native pro-
teins. The constructs were synthesised as synthetic genes, encoding
two identical coil sequences connected via the identiﬁed loop
sequence. The synthesis products were transferred into E. coli
expression vectors to produce fusions with an N-terminal poly-
histidine (6xHis) tag. Overexpression of the SLCC from lactose
inducible promoters in E. coli resulted in the production of inso-
luble target protein, most probably a multimeric complex of
intertwining coils. To circumvent this we adopted a denaturing and
on-resin refolding methodology with Ni-NTA resin. The target
proteins eluted as a soluble species when imidazole was applied and
in high purity, conﬁrmed by mass spectrometry (Supplementary
Fig. 2 and Supplementary Table 1). Typical yields are in the range
15–20mg L−1 culture.
Circular dichroism (CD) measurements have shown that all
three studied proteins consistently produced intense peaks at 220
and 208 nm which are characteristic of an α-helical structure
(Fig. 1e). This suggests that the bridging loop can be readily
substituted without affecting the secondary structure of the
scaffold. MmsFcc demonstrates a slightly higher degree of
α-helical content compared to the other two proteins58. This is
expected due to the shorter, non-helical bridging loop of MmsFcc
compared with AcrBcc and Mms13cc.
We wanted to determine if the proteins were assuming
monomeric coiled coil structures, and exclude the possibility of
dimers, or higher order oligomers. Using a calibrated size
exclusion column, the three proteins were analysed to generate
approximate molecular weights. The retention volumes of each of
the proteins were consistent with the desired monomeric species
(Fig. 1d), with small variances between the constructs matching
the differently sized bridging loops (Fig. 1c). Reassuringly, any
peaks consistent with larger assemblies were completely absent,
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Fig. 1 Design and characterisation of the coiled coil proteins. a TEM image of magnetosomes inside anM. magneticum AMB-1 cell (scale bar is 100 nm) and
b a schematic of the magnetosome membrane and magnetite crystal showing the topology of Mms13 (green) and MmsF (purple) in the membrane with
the transmembrane region shown as cylinders. c Robetta model60 of the coiled coil construct generated in PyMOL68, grey is the homodimeric coiled coil
and red is the variable bridging loop comprising sequences from MmsF, Mms13, and AcrB; d size exclusion chromatography and e circular dichroism
spectra of MmsFcc, Mms13cc, and AcrBcc
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indicating that our samples were both monomeric and
homogeneous.
However, both size exclusion chromatography and CD do not
conclusively conﬁrm the presence of rod-shaped hairpin
structures. To determine both the shape and dimensions of the
coiled coil constructs, small angle X-ray scattering (SAXS)
measurements of puriﬁed MmsFcc with attached 6xHis tag were
collected. A relatively smooth curve was ﬁtted to the experimental
SAXS data in GNOM59, yielding a pair-distance distribution
function P(r) and a radius of gyration of the scattering objects Rg
= 3.7 ± 0.2 nm (Fig. 2). The obtained P(r) pattern revealed that
MmsFcc has a rod-like shape with a maximum length of about 12
nm. This is consistent with our MmsFcc structural models
(Fig. 1c) generated in Robetta60 with the addition of a ﬂexible
6xHis tag. Some oscillations observed in the P(r) are likely to be
related to the periodic nature of the α-helical protein coil.
Using the coiled coil proteins to mediate MNP precipitation.
To study the effect of the coiled coil constructs on the mor-
phology of MNPs during crystallisations, MmsFcc, Mms13cc, and
the negative control protein AcrBcc, were added to magnetite co-
precipitation reactions (Fig. 3a, h, g, respectively). The active
ﬂexible peptide region of MmsF was also added into co-
precipitation reactions to assess the differences between an
unconstrained sequence versus a constrained loop (Fig. 3c). These
reactions were carried out at room temperature, using a ﬁnal
protein concentration of 5 µg mL−1. The nanoparticle products
were compared to particles prepared in the absence of protein
(Fig. 3e, f). Powder X-ray diffraction (XRD) indicated that all of
the samples produced were most likely to be predominately
magnetite (it is not possible to completely rule out the presence of
the closely related iron oxide, maghemite, due to their similar
crystal structure and lattice parameters). Furthermore, XRD will
not resolve amorphous iron oxides or small amounts of crystal-
line alternative iron oxides. However, magnetometry analysis
indicates MmsFcc and Mms13cc particles to be a pure magnetite
product based on their saturation magnetisation, whereas AcrBcc,
and the protein free sample, must comprise a greater proportion
of other non-magnetic iron oxides, as their saturation magneti-
sation is lower (Fig. 4a, b and Table 1).
Transmission electron microscopy (TEM), and subsequent
particle size analysis, showed that the MmsFcc prepared particles
were signiﬁcantly larger (mean Ø 50 nm, standard deviation 13
nm) than either the protein free, Mms13cc, or AcrBcc particles
(Fig. 3i, Supplementary Fig. 3, and Supplementary Table 2) and
comparable in both size, shape, and pure composition to particles
mediated by native MmsF protein (Mms13cc and AcrBcc were
not statistically signiﬁcantly different in size to each other). MNPs
produced in the presence of MmsF24 are shown in Fig. 3d for
comparison. The addition of MmsF unconstrained peptide
resulted in a less controlled material composition (rods and
plates in TEM) and population of wide size distribution (mean Ø
136 nm, standard deviation 69 nm) in stark contrast to the
constrained MmsFcc. Critically, only MNP formed in the
presence of MmsFcc displayed an altered apparent octahedral
morphology, similar to those formed in a high-temperature
synthesis or in the presence of MmsF native protein. Analysis of
the lattice fringes from MmsFcc prepared particles using high-
resolution TEM (Fig. 3b) conﬁrmed the presence of (111) planes
of magnetite, consistent with an octahedral morphology. This
was not observed in the samples produced with any of the
alternative coiled coil constructs, peptide, or from the protein free
reaction.
Probing the proteins for mechanistic insights. We wanted to
understand the interaction between the proteins and the
nanoparticles further, and therefore used a modiﬁed enzyme
linked immunosorbent assay (ELISA) to probe binding43.
Brieﬂy, the puriﬁed protein was mixed with nanoparticles in a
blocking buffer (casein based), and unbound protein was
removed and discarded. The nanoparticles were probed with an
antibody speciﬁc for polyhistidine tags, which in turn was
detected using a conjugated alkaline phosphatase secondary
antibody, yielding a yellow to blue colour change with BluePhos
reagent. We investigated the proteins ability to bind to pre-made
MNPs, as well as to precursor iron oxides which form en route
to magnetite, namely ferric hydroxide and green rust61.
Mms13cc and MmsFcc produced an intense, and highly intense,
colour change respectively in our ELISA system for magnetite,
indicating a positive binding event to this mineral (Fig. 4c and
Supplementary Fig. 4). There was a subtle colour change
observed with AcrBcc, suggesting a very low level interaction.
This indicates that the coiled coil scaffold itself, as well as the
presence of the polyhistidine tag, are not sufﬁcient to produce a
strong, positive, interaction to magnetite on their own. This
allows us to localise the site of binding to the bridging loop
region, effectively the parts of our constructs which are derived
from the magnetotactic bacterial proteins MmsF and Mms13.
MmsFcc appears to bind more strongly than Mms13cc to
MNPs based on ELISA intensity. No signiﬁcant interaction was
observed to the precursor materials for MmsFcc and Mms13cc
compared to the AcrBcc control protein (Supplementary Fig. 5).
We observed a different preference when the proteins were
analysed for ferrous ion binding. In this experiment, puriﬁed
proteins were spotted onto nitrocellulose membrane, before
blocking with bovine serum albumin, and incubating with ferrous
chloride. Metal binding was detected by the ferrous ions ability to
catalyse the breakdown of hydrogen peroxide and trigger
luminescence from applied luminol substrate. Binding was clearly
detected with Mms13cc, with no clear response recorded for the
other two coiled coil proteins tested (Fig. 4c and Supplementary
Fig. 7). It therefore appears from our data that MmsFcc has a
magnetite surface interaction, and Mms13cc has mainly a ferrous
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ion binding, and some magnetite surface interaction. This, along
with the difference seen in the MNPs produced, suggests that
perhaps MmsF and Mms13 have different mechanisms and roles
in vivo.
Discussion
It has been known for 15 years that some biomineralisation
proteins from MTB have the remarkable capacity to direct the
formation of MNPs in vitro as an additive to ‘green’ chemical
synthesis22, with particular control over size25,28, shape24,33, and
directing the composition towards pure magnetite62. Research
interest in using active protein species to direct and tailor
nanomaterial synthesis has developed further, with ever
expanding ranges of materials, as well as an increased under-
standing of the protein interaction with the inorganic materials
they form38. However, the major drawback to developing this
biological/chemical hybrid methodology is the restrictive nature
of producing, processing, and utilising membrane proteins. This
is the case for magnetotactic bacterial-derived biomineralisation
proteins, but is also a wider problem in the development and
analysis of materials and processes involving membrane proteins.
Examples are coming through in which researchers have devel-
oped peptides which are inspired by these biological processes,
and have showed evidence of size and shape control in nano-
particle synthesis38.
In this study, we have designed a functional protein which
retains the activity of the membrane protein but without the
challenging membrane spanning regions. Substituting these
regions for a robust, highly expressible, and soluble coiled
coil scaffold, allows the active biomineralisation loop to be con-
strained between an antiparallel coiled coil, similar to if it were
displayed on the native protein. We have shown this constraint to
be essential, as the unconstrained active peptide alone has a
negative impact on particle formation. We have shown that
MmsFcc is able to control the morphology, size, and composition
of the forming magnetite MNPs. Particles are pure magnetite and
larger (average 50 nm) than control MNPs, and display octahe-
dral crystal planes comparable to high-temperature magnetite
synthesis or MmsF mediated synthesis. However, conversely to
native Mms proteins, the SLCC is much more stable and readily
produced to aid their use within MNP synthesis. This is evident
from the higher expression levels, and as high molecular weight
multi-subunit structures are not required, the SLCC can be easily
and rapidly refolded using on-column methods. The SLCC also
acts as a useful tool to allow the effects of the magnetite inter-
acting loop and multi-subunit self-assembly to be decoupled.
Interestingly we did not see such a marked effect when
Mms13cc was used in the magnetite co-precipitation. Mms6,
Mms13, and MmsF have been studied in vitro, with Mms13
(MamC) found to have a subtle effect, by slightly increasing the
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MNP size25. However, our construct does appear to mimic this
effect with particles slightly larger than those produced protein
free (34 nm versus 21 nm). However, our negative control pro-
tein, AcrBcc also produces a modest increase in mean particle size
(31 nm), so the effect of Mms13cc appears less signiﬁcant. We
cannot exclude the possibility that the scaffold is better able to
match the loop structure from the shorter MmsF sequence than
the much longer Mms13 sequence. Mms13 was discovered tightly
bound to the magnetosome magnetite mineral at the same time as
Mms623. Since this discovery, it has been found that Mms6
activity relies in part on its aggregation and self-assembly to form
a charged surface to bind iron ions and nucleate
mineralisation28,29,31. The propensity to bind iron ions (present
at the initiation of the reaction) rather than the growing mag-
netite MNP, is a hallmark of a nucleating function, as opposed to
a morphological control function. From our data we see that
Mms13cc can bind ferrous ions whereas MmsFcc does not,
indicating a different type of control over crystallisation between
these two proteins. One could extrapolate further to propose that
Mms13 is a nucleation protein and as such may require the ability
to self-assemble, similar to Mms6, in order to create a charged
surface with multiple sites for crystal nucleation. The native
Mms13 protein has the ability to aggregate, while this is missing
in the Mms13cc construct, which could be the reason why no
signiﬁcant effect is observed in magnetite synthesis. Conversely,
MmsFcc does not bind ferrous ions and has been shown to have
morphological control over the MNP formation independent of
protein aggregation. This comparison is further evidence for the
different roles certain magnetosome proteins have in the crys-
tallisation process and the different characteristics required to
perform these roles.
The coiled coil scaffold displays the active loop region from the
native protein in a similar conﬁguration to that proposed to be
displayed in the native protein. The SLCC offers a simple, soluble,
scaffold to display, and topologically constrain, functional peptide
loops from demanding proteins. This has far-reaching implica-
tions: ﬁrstly, it offers a platform for a more tractable way to study
activity in membrane proteins, enabling in-depth characterisation
and understanding. Secondly, it enables the use of previously
inaccessible proteins for synthesis in biotechnology, nano-
technological, and pharmaceutical purposes.
Methods
Protein modelling. The coiled coil construct, MmsF, and Mms13 were modelled
using Robetta60. The crystal structure of AcrB was obtained from the PDB
(accession number: 1IWG). Structures were visualised, and measurements made,
using Pymol software.
Cloning and expression. MmsFcc, Mms13cc, and AcrBcc DNA sequences were
ampliﬁed using PCR. The PCR products were subjected to restriction digest and
ligated into a pPR-IBA1 expression vector. The coiled coil proteins were produced
in BL21 (DE3) E. coli cells as fusion proteins to an N-terminal His8 tag. The
proteins were grown in Super Broth autoinduction media, with trace elements
(Formedium) for 40 h at 37 °C while shaking.
Puriﬁcation. Following autoinduction cells were harvested using centrifugation
(20 min, 3,000 × g). The protein pellet was resuspended in phosphate buffered
saline (PBS) 20% wt/vol, before using sonication to lyse the cells. The lysate was
subjected to centrifugation (40 min, 12,000 × g) and the pellet was recovered. The
pellet was resuspended in 8M GuHCl, 50 mM Tris pH 8, and sonicated once more
to fully disrupt the pellet. Following a ﬁnal centrifugation step (30 min, 12,000 × g)
the supernatant containing the soluble, denatured, protein fraction was recovered.
The soluble protein was mixed with Amintra Ni-NTA resin (Expedeon, UK) and
washed with decreasing concentrations of GuHCl buffer. Finally, the protein was
eluted in PBS containing 300 mM Imidazole pH 7.4. The protein was dialysed
against ultrapure water, and analysed by electrospray ionisation mass spectrometry.
In vitro biomineralisation. Fe3O4 nanoparticles were synthesised using a room
temperature co-precipitation reaction (RTCP) with Fe (II) and Fe (III) sulfates. The
total iron concentration was 50 mM. A 0.5 M NaOH solution was introduced into
the reaction vessel at a rate of 20 µLmin−1. 5 µg mL−1 of protein was added at the
start of the reaction. The reactions were performed with a ratio of the Fe(III) to
total Fe of 0.3, and with four equivalents of sodium hydroxide added. All reactant
solutions were deoxygenated before the experiment by sparging with nitrogen gas.
Nitrogen was also bubbled through the reaction for its entire duration.
Circular dichroism. The puriﬁed protein, present in ultrapure water, was diluted to
a concentration of 0.18 mgmL−1 and insoluble species were removed via cen-
trifugation at 12,000 × g. A Jasco J-810 instrument was used to collect CD spectra.
The protein sample was added to a cuvette with a 2 mm path length and the
wavelength scanned from 260 to 190 nm with a 1 nm slit width and at 1 s intervals
at 20 °C. The process was repeated and the average (minus a protein-free baseline)
was calculated.
Small angle X-ray scattering. SAXS patterns were recorded at a synchrotron
(ESRF, station ID02, Grenoble, France) following established protocols63. A
monochromatic X-ray beam (wavelength λ= 0.0995 nm) and a 2D SAXS detector
(Rayonix MX-170HS) were used for these experiments. A minimum camera length
available at the station (0.8 m) was used to obtain data corresponding to a q range
of 0.1–7.2 nm−1, where
q ¼
4pisinθ
λ
ð1Þ
the modulus of the scattering vector and θ is half of the scattering angle. A ﬂow-
through glass capillary of 1.7 mm diameter was used as a sample holder. A maximum
protein concentration of 2.5 mgmL−1 was used for the measurements. The data were
recorded at 21 °C. In order to obtain the scattering signal of a reasonable intensity for
SAXS analysis at the same time avoiding damage and aggregation of proteins caused
by X-rays, a few experimental protocols with a variable exposure time, a number of
frames and different pauses between the frames have been tested. It has been found
that 10 frames with exposure time of 0.1 s each and 5 s pause between the frames
were an optimal protocol for the SAXS data collection. SAXS measurements
performed at lower q values (0.015 nm−1 < q < 1 nm−1) using a longer camera length
(5m) have also conﬁrmed that no protein aggregation was occurring at these
experimental conditions—the scattering patterns were ﬂat at low q and no upturn of
the scattered signal associated with a protein aggregation was observed. X-ray
scattering data were reduced (integration, normalisation, and subtraction of buffer
solution background scattering) using standard routines available at the beamline
(software package SAXSutilities) and Irena SAS macros for Igor Pro64. The scattering
intensity of water was used for absolute scale calibration of the SAXS data.
Nine dummy atom models were reconstructed using ab initio approach with no
symmetry (space group P1) realised in DAMMIF65, which were then aligned and
averaged in DAMAVER66 with no rejections and a normalised spatial discrepancy
(NSD) of 1.09 ± 0.02. A visual inspection has suggested that all the models have a
similar elongated shape. However, the NSD value is rather high indicating some
systematic differences between the models and, perhaps, a further analysis with extra
conﬁnements associated with the protein structure would be required. Nevertheless,
the most probable SAXS envelope, obtained by removing low occupancy and loosely
connected atoms from the averaged model using DAMFILT, superimposes well with
the protein molecule including the 6xHis-tag (Fig. 2).
Electron microscopy. The nanoparticles were suspended in degassed water then
dried onto glow discharged, carbon-coated copper TEM grids. The particles were
imaged using the FEI Technai G2 Spirit electron microscope, equipped with
camera. For HRTEM a FEI Titan microscope was used. All images were analysed
using ImageJ67, by measuring the particle diameters of 100 particles. MmsF, shown
as a comparison, was from 200 particles24. For shape analysis, we deﬁned particles
which had an aspect ratio ≥1:3 as needle, those <1:3 and with clear facets we
deﬁned as cuboidal, and particles with no clear deﬁnition (e.g. rounded) as irre-
gular. Large (>300 nm) hexagonal plates, likely to be green rust, were discarded
from the analysis as they could not be counted accurately.
Table 1 Nanoparticle characterisation
MNP sample TEM particle
size (nm)a
Crystallite size
(nm)b
Saturation
magnetisation
(emu g−1)
MmsFcc 50 (13) 49 90
Mms13cc 34 (12) 39 93
AcrBcc 31 (14) 35 74
MmsF peptide 136 (69) 59 54
Protein free 21 (6) 38 69
aMean particle size with standard deviation provided in parentheses
bCalculated using the Scherrer equation and the diffraction peak from the [311] magnetite plane
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Powder X-ray diffraction and magnetometry. For X-ray analysis the nano-
particles were dispersed in water following the RTCP. The particles were dried
down into a powder. Powder XRD patterns were collected using a standard X-ray
diffractometer with Bragg–Brentano geometry (Bruker D8, CuK
α
radiation).
Scattering angle 2θ was scanned in a range of 20–80°. The reﬂections observed in
the XRD patterns can be assigned to magnetite crystal structure.
For magnetometry, pre-weighed, dried samples of nanoparticles, were loaded
into gelatine capsules. Data were recorded using an Oxford Instruments Maglab
VSM operating at 55 Hz. The sample temperature was 290 K.
Nanoparticle ELISA. 100 µg of magnetite nanoparticles (NP) were blocked with 2×
blocking buffer (Sigma Blocking solution) in PBS-T. 500 pmol of the coiled coil
protein was added to each sample with binding for 1 h in a volume of 300 µl of 2×
blocking buffer. The NP were washed with PBS-T before addition of rabbit anti-
His6 antibody (Promokine) for 1 h. The NP were washed again, and Anti-Rabbit
IgG alkaline phosphatase conjugate (Sigma Aldrich) was added. After 1 h the NP
were washed with PBS-T three times and detected with Blue-Phos (KPL) reagent.
After 15 min the particles were magnetically removed and the absorbance of the
supernatant at 600 nm was measured. Blue coloured solution indicates binding,
and yellow indicates no/little binding.
Ferrous ion binding. 3 µl of puriﬁed proteins (including ferritin as a positive
control) were spotted onto nitrocellulose membrane at a concentration of 0.2 mg
mL−1. After air drying, the membrane was blocked in 3% wt/vol bovine serum
albumin in PBS-Tween buffer. After 1 h, 200 mM of ferrous chloride was added to
the membrane in deoxygenated blocking solution and allowed to incubate for 3 h
with gentle mixing. The membrane was then washed with PBS-Tween three times,
and once with ultrapure water, to remove excess metal ions. The membrane was
exposed to Clarity ECL detection reagent (Bio-Rad, UK) and visualised with a
Chemi-Doc gel documentation system (Bio-Rad, UK). Bright spots indicate metal
binding.
Data availability
The data/data sources that support the ﬁndings of this paper are contained/cited within
the paper or Supplementary Information. Further raw data and biological materials are
available from the corresponding author upon reasonable request.
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